Recently, three wholly-owned subsidiaries of the Sino-Moor group - Shenzhen Micwell Technology Co., Ltd., Shenzhen Mic Brother Technology Co., Ltd., and Shenzhen Vapsible Technology Co., Ltd. - were granted the "Tobacco Monopoly Production Enterprise License" by the State Tobacco Monopoly Bureau. This certification has strengthened Sino-Moor's confidence in future development, and the overall production and operation of the group will proceed according to its established plan.
Simone will firmly support relevant national policies and operate in accordance with the law. At the same time, driven by scientific and technological advancement, they will actively promote the long-term and healthy development of the industry, serve global customers and users, and fulfill their corporate responsibilities, making positive contributions to society.
The awarding of the "Tobacco Monopoly Production Enterprise License" is a recognition by the government of Sigma's past compliant operations and meticulous management. In the future, Sigma will continue to fulfill regulatory requirements and promote standardized and orderly development.
This article includes excerpts or reprints of content from third-party sources, which belong to the original media and author. If there is any infringement, please contact us for deletion. Any organization or individual who wishes to re-publish must contact the author and avoid direct re-publishing.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
